Prestige Consumer Healthcare (PBH) Operating Income (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Operating Income of $82.5 million for Q4 2025, down 10.3% year-over-year from $92.0 million in Q4 2024, and up 3.54% quarter-over-quarter from $79.7 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Operating Income history runs 16 years deep, the most recent figure standing at $82.5 million for Q4 2025.
- In Q4 2025, Operating Income fell 10.3% year-over-year to $82.5 million; the TTM figure through Dec 2025 stood at $322.3 million (down 2.47% YoY), while the FY2025 annual figure was $336.8 million, down 1.65% from the prior year.
- Operating Income for Q4 2025 stood at $82.5 million, up from $79.7 million in the prior quarter.
- The five-year high for Operating Income was $92.0 million in Q4 2024, with the low at -$281.0 million in Q1 2023.
- The 5-year median for Operating Income is $83.5 million (2021), against an average of $64.6 million.
- The sharpest annual moves came in 2023 and 2024: Operating Income plunged 462.93% in 2023, then surged 129.24% in 2024.
- Prestige Consumer Healthcare's Operating Income stood at $82.6 million in 2021, then grew by 5.56% to $87.2 million in 2022, then dropped by 0.4% to $86.8 million in 2023, then grew by 5.91% to $92.0 million in 2024, then dropped by 10.3% to $82.5 million in 2025.
- Business Quant data shows PBH's Operating Income at $82.5 million in Q4 2025, $79.7 million in Q3 2025, and $71.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.49 Mn |
| Sep 30, 2025 | 79.67 Mn |
| Jun 30, 2025 | 71.76 Mn |
| Mar 31, 2025 | 88.43 Mn |
| Dec 31, 2024 | 91.96 Mn |
| Sep 30, 2024 | 84.34 Mn |
| Jun 30, 2024 | 72.05 Mn |
| Mar 31, 2024 | 82.15 Mn |
| Dec 31, 2023 | 86.83 Mn |
| Sep 30, 2023 | 88.25 Mn |
| Jun 30, 2023 | 85.19 Mn |
| Mar 31, 2023 | -281.00 Mn |
| Dec 31, 2022 | 87.18 Mn |
| Sep 30, 2022 | 84.38 Mn |
| Jun 30, 2022 | 87.01 Mn |
| Mar 31, 2022 | 77.43 Mn |
| Dec 31, 2021 | 82.59 Mn |
| Sep 30, 2021 | 78.56 Mn |
| Jun 30, 2021 | 91.34 Mn |
| Mar 31, 2021 | 70.94 Mn |